•  
  •  
  •  
  •  

2026-07-21 04:41:44

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • RITES & MECON sign MoU to explore business avenues
  • California Software Company Q1 FY27 Results: Consolidated Net Profit Surges 2,071% YoY to ₹4.19 Crore; Revenue Up 329%
  • Swastika Investmart Q1 FY27 Results: Consolidated Net Profit Rises 14.5% YoY to ₹3.76 Crore; Operational Revenue Up 10%
  • Golden Legand Leasing and Finance Q1 FY27 Results: Net Profit Drops 88.8% YoY to ₹54.89 Lakh Amid Top-Line Contraction
  • Authum Investment & Infrastructure Q1 FY27 Net Profit Rises 17.5% YoY to ₹1,108 Crore; Total Income Up 21.3%

Keywords Selected:  InjectableFacility

Stock Report

  • Alembic Pharmaceuticals Ltd receives 2 observations for Karakhadi Injectable Facility
  • Lupin receives EIR from US FDA for its Nagpur Injectable Facility
  • Zydus receives EIR for the injectable facility located at Jarod
  • Closure of USFDA inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Zydus receives EIR for the oncology injectable manufacturing facility in SEZ1, Ahmedabad
  • Lupin receives 6 observations from USFDA for Nagpur Injectable facility
  • Eris Lifesciences receives ANVISA approval for Sterile Injectable Facility
  • Lupin receives EIR from US FDA for its Injectable Facility in Nagpur
  • Eugia Steriles Pvt Ltd receives EIR from USFDA for new injectable facility
  • Eugia Steriles Pvt Ltd receives 1st production approval from USFDA from new injectable facility
  • Lupin announces closure of US FDA Inspection at its Injectable Facility with Zero 483 Observations
  • Eugia Steriles Pvt Ltd gets 3 observations from USFDA for Injectable Facility
  • Windlas Biotech Limited commissions its State-of-the-Art Injectable facility
  • Eugia US Manufacturing LLC gets 10 observations from USFDA for East Windsor facility
  • Lupin Receives EIR from US FDA for its Injectable Facility in Nagpur
  • Alembic Pharmaceuticals Ltd receives EIR from USFDA for Injectable Facility at Karkhadi
  • Lupin receives approval from US FDA for Glycopyrrolate Injection, USP
  • USFDA inspection at Alembic Pharmaceuticals Injectable Facility (F-3) at Karkhadi
  • Zydus Lifesciences Ltd gets 3 observations from USFDA for Injectable Facility

Latest Post

  • RITES & MECON sign MoU to explore business avenues
  • California Software Company Q1 FY27 Results: Consolidated Net Profit Surges 2,071% YoY to ₹4.19 Crore; Revenue Up 329%
  • Swastika Investmart Q1 FY27 Results: Consolidated Net Profit Rises 14.5% YoY to ₹3.76 Crore; Operational Revenue Up 10%
  • Golden Legand Leasing and Finance Q1 FY27 Results: Net Profit Drops 88.8% YoY to ₹54.89 Lakh Amid Top-Line Contraction
  • Authum Investment & Infrastructure Q1 FY27 Net Profit Rises 17.5% YoY to ₹1,108 Crore; Total Income Up 21.3%


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025